The Campbell’s Company (NasdaqGS:CPB) Q1 2026 Earnings Call December 09, 2025 08:00 AM ET Speaker1Good morning and welcome to The Campbell's Company First Quarter Fiscal 2026 Earnings Conference Call. Today's conference is being recorded. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end. If you would like to ask a question, please press star one on your telephone keypad. I would now like to turn the call over to Rebecca Gardy, Chie ...

Core Viewpoint - Campbell Soup Company is facing a public relations crisis following allegations against an executive, Martin Bally, who reportedly made derogatory comments about the company and its customers, leading to an investigation and his leave of absence [1][5]. Group 1: Allegations and Investigation - Martin Bally, the vice president of information technology at Campbell, has been placed on leave while the company investigates claims made in a lawsuit regarding his inappropriate remarks [1]. - The lawsuit was filed by Robert Garza, a former cybersecurity analyst, who claims he was terminated after raising concerns about Bally's comments [1][2]. Group 2: Content of Allegations - The lawsuit includes a recorded meeting where Bally allegedly insulted his Indian colleagues and described Campbell's products as catering to "poor people" [2]. - In the recording, the individual reportedly criticized Campbell's food as "unhealthy" and referred to its chicken as "bioengineered" and "3D-printed" [3][4]. Group 3: Company Response - Campbell Soup Company has publicly denounced the remarks attributed to Bally, stating they are "patently absurd" and affirming that their chicken meat comes from trusted USDA-approved suppliers [4]. - The company emphasized that Bally's role in IT does not involve food production, distancing itself from his comments [4]. Group 4: Broader Implications - The controversy has attracted attention from Florida Attorney General James Uthmeier, who announced an investigation into the company, particularly concerning the legality of lab-grown meat in Florida [5]. - Bally also criticized the company's acquisition of Sovos Brands for $2.7 billion, suggesting it was an overpayment for a mere "recipe and a brand" without owning manufacturing capabilities [6].

Financial Performance - Q4 Fiscal Year 2025 - Net sales increased by 1% to $2321 million compared to Q4 FY24[19, 68] - Organic net sales decreased by 3% compared to Q4 FY24[19, 68] - Adjusted EBIT decreased by 2% compared to Q4 FY24, reaching $321 million[19, 68] - Adjusted EPS decreased by 2% compared to Q4 FY24, amounting to $062[19, 68] Financial Performance - Full Fiscal Year 2025 - Net sales increased by 6% to $10253 million compared to FY24[19, 71] - Organic net sales decreased by 1% compared to FY24[19, 71] - Adjusted EBIT increased by 2% compared to FY24, reaching $1487 million[19, 71] - Adjusted EPS decreased by 4% compared to FY24, amounting to $297[19, 71] Segment Performance - Meals & Beverages organic net sales decreased by 3% in Q4 FY25[35] - Snacks organic net sales decreased by 2% in Q4 FY25[51] Fiscal Year 2026 Guidance - The company expects net sales to decline by 2% to 0%[109] - Organic net sales are projected to range from -1% to +1%[109] - Adjusted EBIT is expected to decline by 13% to 9%[109] - Adjusted EPS is projected to be in the range of $240 to $255[109]